Analyst Ratings for Chimera Investment Corp (CIM) [Sells]
CIM Rating Summary
CIM Price Target Summary
- Highest: $6.00 (RBC Capital)
- Lowest: $5.50 (Credit Suisse)
- Average: $5.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.67 (+37.9%)
* Over Last 12-Mos
Rating Score: 1.3 / 10
Percentile Rank: 9%
Avg. $ Target:
$5.67 (+37.9%)
* Over Last 12-Mos
Rating Score: 1.3 / 10
Percentile Rank: 9%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/10/2020 | Barclays » Updated 7/18/2022 |
Mark DeVries | Downgrade | Underweight (Equalweight) |
9.00 (11.00) |
10.88 (4.11) |
-62.22% | Details |
| 6/21/2012 | BofA Securities | N/A | Downgrade | Underperform (N/A) |
N/A (N/A) |
2.74 (4.11) |
50% | Details |
 |
||||||||
